|
|
Article: Clinic Roundup.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o AnorMed Inc., of Vancouver, British Columbia, finished enrolling 300 multiple myeloma patients in the first of two pivotal Phase III trials of Mozobil for stem cell transplant. Recruitment continues for the second Phase III study in non-Hodgkin's lymphoma, and 300 patients are expected to be enrolled in that trial by the end of the year. Both trials are designed to evaluate Mozobil in a standard stem cell mobilization regimen. AnorMed anticipates reporting top-line data by the second quarter of 2007.
o BioAxone Therapeutic Inc., of Montreal, completed its targeted patient enrollment of the Phase I/IIa North American trial of Cethrin in acute spinal cord injury. ...